Despite No Surprises Is Annaly Capital Management, Inc. (NLY) Still a Buy?

Page 1 of 2

Annaly Capital (NLY)Annaly Capital Management, Inc. (NYSE:NLY) commenced operations in 1997 as a mortgage REIT with the objective of providing its shareholders elevated returns primarily through dividends. The company is self-managed and seeks to invest at least 75% of its total assets in high quality mortgage-backed securities and short term investments. The company’s charter allows the management to invest the remaining 25% of assets in unrated or less than high quality assets but that are at least investment grade. The company is currently invested in mortgage-backed securities backed by single-family residential mortgage loans as well as securities backed by loans on multi-family and commercial properties. At the end of the fourth quarter, around 93% of the securities that NLY held were fixed rate Agency MBS and debentures, while the remaining 7% was adjustable-rate Agency MBS and debentures. NLY entered in a contract to swap around 40% of the Agency MBS’s interest rates.

Earnings Review

Annaly Capital reported its performance for the fourth quarter of 2012 on Feb. 6, 2013. The reported bottom line of $700.5 million or $0.7 per common share for the quarter climbed 52% from a year ago, while it is over two-fold the bottom line of the linked quarter. Much of the sequential surge in the bottom line was a result of unrealized gains and losses on interest rate swaps Agency interest-only mortgage backed securities and net losses on extinguishment of Convertible Senior Notes.

Interest income has continued its downward journey since the second quarter of 2012. For the fourth quarter, interest income of $756.6 million fell 60 basis points over the linked quarter. Part of the reason for such a decline in interest income was the 4.3% decline in Agency mortgage-backed securities that NLY held. The weighted average yield on interest yielding assets declined 47 basis points over the same time period, causing the interest income to decline further.

Interest expense on the other hand surged. During the fourth quarter, NLY incurred $185.5 million in interest expense, compared to $181.9 million during the linked quarter. The rise in interest expense was a result of the higher cost of repurchase agreements, partially offset by a decline in the cost of Convertible Senior debt. The weighted average cost of funds during the fourth quarter dipped over the linked quarter from 1.6% to 1.55%.

As a result, net interest income of $571 million for the fourth quarter declined 1.4% over the linked quarter. Other income of $49.8 million declined 2% over the third quarter, largely due to lower net gains on disposal of investments, partially offset by higher net gains on trading assets. Unrealized gains on interest rate swaps produced $341.5 million against a loss of $104.2 million during the third quarter.

During the fourth quarter, NLY managed its general and administrative expenses well as they came down 36% sequentially to $40.1 million. Much of the improvement was a result of lower compensation expense, which still happens to be the largest contributor in expenses. The general and administrative expenses as a percentage of average assets declined to 0.12% from the linked quarter’s ratio of 0.19%.

Prepayment Speeds

Annaly reported 19% CPR for its MBS portfolio at the end of the fourth quarter. This is compared to 20% prepayment speed for its portfolio at the end of the third quarter. Lesser CPR means lower premium amortization cost. Therefore, net amortization of premiums and accretion of discounts for the fourth quarter were reported at $433.3 million, down 5% compared to the linked quarter.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!